Press "Enter" to skip to content

New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30 PENFILL

0

Annual Drug Patent Expirations for NOVOLOG+MIX+70%2F30+PENFILL
Annual Drug Patent Expirations for NOVOLOG+MIX+70%2F30+PENFILL

Novolog Mix 70/30 Penfill is a drug marketed by Novo Nordisk Inc
and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug.

The generic ingredient in NOVOLOG MIX 70/30 PENFILL is insulin aspart protamine recombinant; insulin aspart recombinant. Two suppliers are listed for this compound. Additional details are available on the insulin aspart protamine recombinant; insulin aspart recombinant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Do NOT follow this link or you will be banned from the site!